Olr1470 inhibitors are a class of chemical compounds specifically designed to target and inhibit the Olr1470 receptor, a member of the olfactory receptor family within the larger group of G-protein coupled receptors (GPCRs). These receptors are integral to the olfactory system, where they play a key role in detecting and transducing odorant signals into cellular responses. The Olr1470 receptor, like other GPCRs, functions by binding to specific odorant molecules, which triggers a series of intracellular events leading to signal transmission. Inhibitors of Olr1470 are developed to bind to the receptor in such a way that they block the binding of its natural ligands, effectively preventing the receptor from initiating its normal signaling processes. This inhibition can be achieved through molecules that either occupy the receptor's active site or interact with allosteric sites, altering the receptor's conformation and hindering its function.
The chemical development of Olr1470 inhibitors involves a meticulous process of optimizing several key properties to ensure effective inhibition of the receptor. Researchers often employ techniques such as molecular docking, which allows them to simulate the interaction between potential inhibitors and the Olr1470 receptor, providing insights into how well these molecules fit into the receptor's binding sites. Additionally, high-throughput screening is used to evaluate large libraries of compounds, identifying those with the strongest inhibitory effects on Olr1470. Once promising candidates are identified, structure-activity relationship (SAR) studies are conducted to refine the chemical structure of these inhibitors, enhancing their binding affinity, selectivity, and overall stability. These studies may involve modifying the core chemical scaffold of the inhibitors, as well as adjusting functional groups to improve interactions with the receptor. Furthermore, factors such as solubility, lipophilicity, and metabolic stability are carefully considered to ensure that the inhibitors can effectively interact with the Olr1470 receptor in various conditions. The development of Olr1470 inhibitors provides valuable insights into the chemical mechanisms of receptor inhibition and the broader understanding of olfactory signal transduction.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Benidipine | 105979-17-7 | sc-278724 | 100 mg | $650.00 | ||
Calcium channel blocker, may indirectly affect GPCR signaling through calcium ion modulation, impacting Olr1470. | ||||||
Captopril | 62571-86-2 | sc-200566 sc-200566A | 1 g 5 g | $48.00 $89.00 | 21 | |
ACE inhibitor, can modulate GPCR signaling indirectly via the renin-angiotensin system, impacting Olr1470. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $122.00 $235.00 $520.00 $979.00 $1500.00 | 2 | |
Beta-adrenergic receptor antagonist, might influence GPCR signaling pathways indirectly, impacting Olr1470. | ||||||
Manidipine | 89226-50-6 | sc-211774 | 10 mg | $278.00 | ||
Calcium channel blocker, might modulate GPCR signaling indirectly via calcium ion regulation, impacting Olr1470. | ||||||
Nitrendipine | 39562-70-4 | sc-201466 sc-201466A sc-201466B | 50 mg 100 mg 500 mg | $107.00 $157.00 $449.00 | 6 | |
Calcium channel blocker, may alter GPCR signaling indirectly through calcium modulation, impacting Olr1470. | ||||||
Telmisartan | 144701-48-4 | sc-204907 sc-204907A | 50 mg 100 mg | $71.00 $92.00 | 8 | |
Angiotensin II receptor blocker, might indirectly influence GPCR signaling, impacting Olr1470. | ||||||